...tome Company has joined forces with the Mickle Lab...tome 800 Tissue Chopper. This tissue sectioning sy...ue for metabolic experiments and to be especially ...ble at biopsy or from small organs. Its special fe...
... Custom Peptide Services offer a full range of pep.... Services include: Peptide synthesis, crude prod... purified product (70-95% pure) Labels & modifi...uorescein, myristylation, phosphorylation, and rho...
...Frame DNAscope is an integrated confocal laser sca...adily integrated into your specific application. G...r we can tailor the system to your specifications....ng design has been modularized and built onto an o...
Dulbecco's Phosphate Buffered Saline (DPBS) from Sigma-Aldrich
Biology Products:(Date:11/23/2009)...o-dimensional carbon layer in which the carbon ato... a honeycomb. Carbon nanotubes are rolled-up sheet...form graphite. Graphene boasts some very special c... excellent thermal conductor, and reconciles such .... In addition, graphene is impermeable to gases, w...
(Date:11/23/2009)...23/PRNewswire-FirstCall/-YMBioSciencesInc.(NYSEAme...panythatidentifiesandadvancesadiverseportfolioofpr...lopment,todayreportedthatCytopia(ASX:CYT)hascommen...tent,orally-administeredJAK1/JAK2inhibitor.Thetria....AproposaltomergeCytopiaintoYMhasbeenpreviouslyann...
(Date:11/23/2009)...ontec’s Sporicidin disinfectant solution and...isinfectants against H1N1 and Influenza A., , ...ber 24, 2009 -- Contec Inc, the leading manufactur...eir Sporicidin disinfectants have been deemed by...ses, including Pandemic 2009 H1N1 influenza A viru...
(Date:11/23/2009)...RNewswire/-InimexPharmaceuticals,Inc.announcedtoda...entandCEO. ,, Abramsbringsmorethan25yearsofdrug...inventorofthenuclearmedicineimagingagent,Cardiolit...hewasManager,BiomedicalResearchWorldwide.In1996,Ab...PresidentandCEOfrom1996to2006.AnorMEDdiscoveredand...
Breaking Biology Technology:Polymer with honeycomb structure 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Inimex Announces Appointment of New CEO 2